Dechra Pharmaceuticals PLC — AGM Information 2022

Oct 20, 2022

National Storage Mechanism | Additional information

RNS Number : 6006D

Dechra Pharmaceuticals PLC

20 October 2022

Thursday, 20 October 2022

Dechra® Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

A poll was held on each of the resolutions proposed at the Annual General Meeting (AGM) of the Company held today

(20 October 2022).  All resolutions were passed and are as follows:

Resolution (No. as noted on proxy form)	Total For (includes Discretionary)		Total Against		Total Cast (excludes Withheld)		Withheld (1)
	No. of votes	% of vote	No. of votes	% of vote	No. of votes	% of vote	No. of votes
Ordinary Business:
Resolution 1: To receive the accounts, the Strategic Report, the Directors' Report and the Auditor's Report	82,263,193	99.89%	90,162	0.11%	82,353,355	72.35	849,642
Resolution 2: To approve the Directors' Remuneration Report	79,297,256	95.31%	3,901,808	4.69%	83,199,064	73.10	3,933
Resolution 3: To declare a final dividend	83,199,118	100.00%	1,739	0.00%	83,200,857	73.10	2,140
Resolution 4: To elect John Shipsey	82,225,331	98.83%	974,701	1.17%	83,200,032	73.10	2,965
Resolution 5: To re-elect Alison Platt	70,534,490	93.25%	5,105,848	6.75%	75,640,338	66.46	7,562,659
Resolution 6: To re-elect Ian Page	81,717,540	98.22%	1,480,147	1.78%	83,197,687	73.10	5,310
Resolution 7: To re-elect Anthony Griffin	81,729,006	98.23%	1,471,081	1.77%	83,200,087	73.10	2,910
Resolution 8: To re-elect Paul Sandland	81,598,155	98.07%	1,601,932	1.93%	83,200,087	73.10	2,910
Resolution 9: To re-elect Lisa Bright	81,024,175	97.39%	2,174,336	2.61%	83,198,511	73.10	4,486
Resolution 10: To re-elect Lawson Macartney	80,756,857	97.06%	2,443,175	2.94%	83,200,032	73.10	2,965
Resolution 11: To re-elect Ishbel Macpherson	80,852,117	97.18%	2,346,393	2.82%	83,198,510	73.10	4,487
Resolution 12: To re-appoint PricewaterhouseCoopers as external auditor of the company	82,422,445	99.08%	766,389	0.92%	83,188,834	73.09	14,163
Resolution 13: To authorise the Audit Committee to determine the remuneration of the external auditor	83,082,125	99.86%	118,208	0.14%	83,200,333	73.10	2,664
Special Business:
Resolution 14: To authorise the directors to allot shares to specific limits	75,904,608	91.23%	7,296,215	8.77%	83,200,823	73.10	2,174
Resolution 15: To disapply the pre-emption rights	81,644,651	98.13%	1,552,203	1.87%	83,196,854	73.09	6,143
Resolution 16: To disapply additional pre-emption rights	80,880,510	97.22%	2,316,443	2.78%	83,196,953	73.09	6,044
Resolution 17: To authorise the Company to purchase its own shares	82,445,021	99.11%	737,441	0.89%	83,182,462	73.08	20,535
Resolution 18: To authorise the Company to hold any general meeting (other than an AGM) on not less than 14 clear days' notice	78,978,217	94.92%	4,222,557	5.08%	83,200,774	73.10	2,223

Notes:

1.       A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

2.       Resolutions 1 to 14 were ordinary resolutions, requiring more than 50% of shareholder votes to be "For" the resolutions.

3.       Resolutions 15 to 18 were special resolutions, requiring more than 75% of shareholder votes to be "For" the resolutions.

4.       Issued Share Capital at meeting date: 113,820,672

5.       Equiniti, Registrar to the Company, were appointed for the purpose of the Poll taken at the AGM and certify as scrutineer that the result of the Poll is correctly set out above.

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

For further information, please contact:

Melanie Hall

Company Secretary

Dechra Pharmaceuticals PLC

Telephone: +44 (0) 1606 814 730

Email: corporate.enquiries@dechra.com 

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.  For more information, please visit: www.dechra.com.

Trademarks

Trademarks appear throughout this document in italics.  Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFELFDSEESELS